Download PDF
CC BY-NC-ND 4.0 · Journal of Academic Ophthalmology 2022; 14(02): e187-e192
DOI: 10.1055/s-0042-1755581
Research Article

Current Landscape of Uveitis Specialists in the United States

Edmund Tsui 
1   Ocular Inflammatory Disease Center, UCLA Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, California
,
Eric L. Crowell
2   Mitchel and Shannon Wong Eye Institute, UT Health Austin, Austin, Texas
,
Sapna Gangaputra
3   Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee
,
Kareem Moussa
4   UC Davis Health Eye Center, Sacramento, California
,
Jessica G. Shantha
5   Francis I. Proctor Foundation, UCSF, San Francisco, California
,
Alexander J. Shusko
1   Ocular Inflammatory Disease Center, UCLA Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, California
,
Ian A. Thompson
6   Southwest Retina Consultants, El Paso, Texas
,
Derek C. Pham
7   Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
,
Nicholas J. Jackson
7   Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
,
Arthi G. Venkat
8   Retina Group of Washington, Washington, District of Columbia
› Author Affiliations Funding S.G., MERITCRO (Consultant); E.T.: Kowa Company Ltd (research grant), Cylite Pty Ltd (research grant), Thrasher Research Fund (research grant), Knights Templar Eye Foundation (research grant), National Eye Institute K23EY032990 (research grant). Other authors have no financial disclosures.
› Further Information
   Permissions and Reprints

Abstract

Purpose This study characterizes the current landscape of uveitis specialists and their practice settings in the United States.

Methods An anonymous Internet-based survey with questions pertaining to training history and practice characteristics was distributed via REDCap to the American Uveitis Society and Young Uveitis Specialists listservs.

Results Forty-eight uveitis specialists in the United States responded to the survey out of 174 uveitis specialists that identify as practicing in the United States. Twenty-five of 48 respondents (52%) completed an additional fellowship. These additional fellowships ranged from surgical retina (12/25, 48%), cornea (8/25, 32%), and medical retina (4/25, 16%). Two-thirds of uveitis specialists managed their own immunosuppression, while one-third comanaged immunosuppression with rheumatologists. Thirty-three of 48 (69%) maintained a surgical practice.

Conclusion This is the first survey of uveitis specialists across the United States to provide understanding into training and practice characteristics. These data will provide insight into career planning, practice building, and assist in resource allocation.

Keywords

uveitis - fellowship - immunosuppression - retina

Supplementary Material



Publication History

Received: 13 April 2022

Accepted: 20 July 2022

Article published online:
29 August 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Thorne JE, Suhler E, Skup M. et al. Prevalence of noninfectious uveitis in the United States: a claims-based analysis. JAMA Ophthalmol 2016; 134 (11) 1237-1245
    CrossrefPubMedGoogle Scholar
  • 2 Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 1996; 80 (09) 844-848
    CrossrefPubMedGoogle Scholar
  • 3 American Uveitis Society. Uveitis Specialist Directory. Accessed March 1, 2021, at: https://uveitissociety.org/directory
    PubMedGoogle Scholar
  • 4 Zafar S, Bressler NM, Golnik KC. et al. Fellowship match outcomes in the U.S. from 2010 to 2017: analysis of San Francisco Match. Am J Ophthalmol 2020; 218: 261-267
    CrossrefPubMedGoogle Scholar
  • 5 Match SF. Ophthalmology Fellowship Statistics, 2021. Accessed June 1, 2022, at: https://sfmatch.org/specialty/b5787c77-2a6d-4ca4-b6b0-11996fd5d627/9a6b4fa7-57e1-4e67-9716-84553e0b7df4
    PubMedGoogle Scholar
  • 6 Chen X, Zafar S, Srikumaran D. et al. Factors influencing postgraduate career decisions of ophthalmology residents. J Acad Ophthalmol 2020; 12: e124-e133
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Jabs DA. Immunosuppression for the uveitides. Ophthalmology 2018; 125 (02) 193-202
    CrossrefPubMedGoogle Scholar
  • 8 Smith JR, Jabs DA, Briceland DJ, Holland GN. Education in the ophthalmic discipline of uveitis. Am J Ophthalmol 2008; 146 (06) 799-801
    CrossrefPubMedGoogle Scholar
  • 9 Jabs DA, Busingye J. Approach to the diagnosis of the uveitides. Am J Ophthalmol 2013; 156 (02) 228-236
    CrossrefPubMedGoogle Scholar
  • 10 Burkholder BM, Jabs DA. Uveitis for the non-ophthalmologist. BMJ 2021; 372: m4979
    CrossrefPubMedGoogle Scholar
  • 11 Kempen JH, Gangaputra S, Daniel E. et al. Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol 2008; 146 (06) 802-12.e1
    CrossrefPubMedGoogle Scholar
  • 12 Lee CS, Randhawa S, Lee AY, Lam DL, Van Gelder RN. Patterns of laboratory testing utilization among uveitis specialists. Am J Ophthalmol 2016; 170: 161-167
    CrossrefPubMedGoogle Scholar
  • 13 Berkenstock M, Mopuru R, Thorne J, Scott AW. Analysis of new cases of uveitis at academic and community settings. Br J Ophthalmol 2021; 105 (06) 779-782
    CrossrefPubMedGoogle Scholar
  • 14 McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. UCLA Community-Based Uveitis Study Group. Causes of uveitis in the general practice of ophthalmology. Am J Ophthalmol 1996; 121 (01) 35-46
    CrossrefPubMedGoogle Scholar
  • 15 Ferrara M, Eggenschwiler L, Stephenson A. et al. The challenge of pediatric uveitis: tertiary referral center experience in the United States. Ocul Immunol Inflamm 2019; 27 (03) 410-417
    CrossrefPubMedGoogle Scholar
  • 16 Pistilli M, Joffe MM, Gangaputra SS. et al; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group. Visual acuity outcome over time in non-infectious uveitis. Ocul Immunol Inflamm 2021; 29 (06) 1064-1071
    CrossrefPubMedGoogle Scholar
  • 17 Cheung CS, Noordeh N, Gottlieb CC. A national survey of Canadian ophthalmologists to determine awareness of published guidelines for the management of uveitis. J Ophthalmic Inflamm Infect 2016; 6 (01) 38
    CrossrefPubMedGoogle Scholar
  • 18 Felfeli T, Christakis PG, Bakshi NK, Mandelcorn ED, Kohly RP, Derzko-Dzulynsky LA. Referral characteristics and wait times for uveitis consultation at academic tertiary care centres in Toronto. Can J Ophthalmol 2018; 53 (06) 639-645
    CrossrefPubMedGoogle Scholar
  • 19 Ozzello DJ, Palestine AG. Factors affecting therapeutic decisions in intermediate and posterior uveitis. Am J Ophthalmol 2015; 159 (02) 213-20.e3
    CrossrefPubMedGoogle Scholar
  • 20 Smith JR, Jabs DA, Van Gelder RN. Uveitis is a subspeciality. Ophthalmology 2012; 119 (04) 887-888 , author reply 888
    CrossrefPubMedGoogle Scholar